Cargando…
Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development
Around 11% of all known gene lesions causing human genetic diseases are nonsense mutations that introduce a premature stop codon (PTC) into the protein-coding gene sequence. Drug-induced PTC readthrough is a promising therapeutic strategy for treating hereditary diseases caused by nonsense mutations...
Autores principales: | Li, Shan, Li, Juan, Shi, Wenjing, Nie, Ziyan, Zhang, Shasha, Ma, Fengdie, Hu, Jun, Chen, Jianjun, Li, Peiqiang, Xie, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296333/ https://www.ncbi.nlm.nih.gov/pubmed/37371567 http://dx.doi.org/10.3390/biom13060988 |
Ejemplares similares
-
Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR
por: Smith, Emery, et al.
Publicado: (2020) -
The unfolded protein response affects readthrough of premature termination codons
por: Oren, Yifat S, et al.
Publicado: (2014) -
Ataluren—Promising Therapeutic Premature Termination Codon Readthrough Frontrunner
por: Michorowska, Sylwia
Publicado: (2021) -
Letter to the Editor: Liver Cell Models for Premature Termination Codon Readthrough Analyses
por: Matakovic, Lavinija, et al.
Publicado: (2021) -
635 Genome-wide screen to uncover genes promoting premature termination codon readthrough
por: Wong, E., et al.
Publicado: (2022)